Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease

Journal of Neurology

Volumn 256, Issue 11, 2009, Pages 1809-1815

  Rodrigues, Guilherme Riccioppo ^a   Souza, Carolina Pinto ^a   Cetlin, Roberto Satler ^a   De Oliveira, Daniel Sabino ^a   Pena Pereira, Marcio ^a   Ujikawa, Liliana Tiemi ^a   Marques Jr , Wilson ^a   Tumas, Vitor ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Executive function; Frontal assessment battery; Huntington's disease

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; COGNITIVE DEFECT; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; COGNITION DISORDERS; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 73449130230     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5197-0     Document Type: Article

References (34)

1. Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The Frontal Assessment Battery (FAB): Normative values in an Italian population sample. Neurol Sci 26(2):108-116 (Pubitemid 40975511)
2. Beato RG, Nitrini R, Formigoni AP, Caramelli P (2007) Brazilian version of the Frontal Assessment Battery (FAB). Preliminary data on administration to healthy elderly. Dementia Neuropsychol 1:59-65
3. Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T (2005) Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol 252:36-41 (Pubitemid 40179016)
4. Benton AL, Hamsher K de S (1978) Multilingual aphasia examination manual. University of Iowa, Iowa City
5. Brandt J, Folstein SE, Folstein MF (1988) Differential cognitive impairment in Alzheimer disease and Huntington's disease. Ann Neurol 23:555-561
6. Brown RG, Marsden CD (1988) 'Subcortical dementia': The neuropsychological evidence. Neuroscience 25:363-387
7. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH (2003) Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 61:777-781 (Pubitemid 37236632)
8. Caine ED, Shoulson I (1983) Psychiatric syndromes in Huntington's disease. Am J Psychiatr 140:728-733 (Pubitemid 13094138)
9. de Tommaso M, Difruscolo O, Sciruicchio V, Specchio N, Livrea P (2007) Two years' follow-up of rivastigmine treatment in Huntington disease. Clin Neuropharmacol 30:43-46 (Pubitemid 46204317)
10. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: A Frontal Assessment Battery at bedside. Neurology 55:1621-1626
11. Folstein MF, Folstein SE, McHugh PR (1975) ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
12. Hahn-Barma V, Deweer B, Durr A, Dode C, Feingold J, Pillon B, Agid Y, Brice A, Dubois B (1998) Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatr 64:172-177 (Pubitemid 28159797)
13. Helder DI, Kaptein AA, van Kempen GM, van Houwelingen JC, Roos RA (2001) Impact of Huntington's disease on quality of life. Mov Disord 16:325-330 (Pubitemid 36061169)
14. Huntington Study Group (1996) Unified Huntington's Disease Rating Scale: Reliability and consistency. Mov Disord 11:136-142
15. Jason GW, Suchowersky O, Pajurkova EM, Graham L, Klimek ML, Garber AT, Poirier-Heine D (1997) Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch Neurol 54:1081-1088 (Pubitemid 27396475)
16. Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56:563-568 (Pubitemid 29218151)
17. Kugo A, Terada S, Ata T, Ido Y, Kado Y, Ishihara T, Hikiji M, Fujisawa Y, Sasaki K, Kuroda S (2007) Japanese version of the Frontal Assessment Battery for dementia. Psychiatry Res 153(1):69-75 (Pubitemid 47374822)
18. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245-1249 (Pubitemid 8065643)
19. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R (2004) Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-A longitudinal follow-up study. J Neurol 251:935-942 (Pubitemid 39119311)
20. Lima CF, Meireles LP, Fonseca R, Castro SL, Garrett C (2008) The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol 255(11):1756-1761
21. Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH (2005) Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology 65:726-731 (Pubitemid 41285852)
22. Mahant N, McCusker EA, Byth K, Graham S (2003) Huntington's disease: Clinical correlates of disability and progression. Neurology 61:1085-1092 (Pubitemid 37461942)
23. Oguro H, Yamaguchi S, Abe S, Ishida Y, Bokura H, Kobayashi S (2006) Differentiating Alzheimer's disease from subcortical vascular dementia with the FAB test. J Neurol 253:1490-1494 (Pubitemid 44950284)
24. Ready RE, Mathews M, Leserman A, Paulsen JS (2008) Patient and caregiver quality of life in Huntington's disease. Mov Disord 23:721-726
25. Rosenblatt A, Liang KY, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA (2006) The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66:1016-1020 (Pubitemid 44044784)
26. Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B (2004) Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol 61:1104-1107 (Pubitemid 38915953)
27. Smith A (1973) Symbol digit modalities test manual. Western Psychological Services, Los Angeles
28. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
29. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
30. Tumas V, Camargos ST, Jalali PS, Galesso Ade P, Marques W Jr (2004) Internal consistency of a Brazilian version of the unified Huntington's disease rating scale. Arq Neuropsiquiatr 62:977-982 (Pubitemid 40013094)
31. van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, van der Mast RC (2008) Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative firstdegree relatives. J Clin Psychiatry 69(11):1804-1810
32. Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D (2007) Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 14:1344-1350 (Pubitemid 350135299)
33. Warner JP, Barron LH, Brock DJ (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 7:235-239 (Pubitemid 23232244)
34. Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B (2008) Altered frontostriatal coupling in pre-manifest Huntington's disease: Effects of increasing cognitive load. Eur J Neurol 15(11):1180-1190